Related Experiment Video
Updated: Jul 14, 2026

10:25
Brain Infarct Segmentation and Registration on MRI or CT for Lesion-symptom Mapping
Published on: September 25, 2019
Multiscale extraction of hypodensity in hyperacute stroke.
Katarzyna Sklinda1, Paweł Bargiel, Artur Przelaskowski
1Department of Radiology CMKP, CSK MSWiA, Warszawa, Poland. rtg@cskmswia.pl <rtg@cskmswia.pl>
Summary
A new wavelet-based "stroke monitor" improves early stroke detection on CT scans, aiding diagnosis, especially in patients with brain atrophy. This enhances patient selection for crucial thrombolytic therapy.
Area of Science:
- Neurology
- Radiology
- Medical Imaging Analysis
Background:
- Stroke, a sudden neurological deficit from cerebral ischemia, requires timely diagnosis.
- Computed tomography (CT) is vital for stroke evaluation but struggles to detect hypodense areas in hyperacute ischemic stages.
- Accurate identification of ischemic tissue is critical for safe and effective thrombolytic therapy.
Purpose of the Study:
- To introduce and evaluate a novel wavelet-based post-processing method for enhancing hypodensity detection in CT scans of hyperacute stroke patients.
- To assess the diagnostic performance improvement offered by this method compared to standard CT interpretation.
Main Methods:
- Retrospective analysis of 52 stroke patient CT scans by four radiologists.
- Initial evaluation of CT scans followed by reevaluation with an added "stroke monitor" tool.
- Diagnosis confirmation through follow-up CT or clinical data.
Main Results:
- The "stroke monitor" significantly improved the area under the curve (AUC) for radiological diagnosis across all participating radiologists.
- This improvement was statistically significant (p<0.05) in most subgroups.
- The enhancement was particularly noted in cases involving patients with significant cerebral atrophy.
Conclusions:
- Integrating CT findings with the "stroke monitor" enhances stroke diagnosis accuracy, especially in cases of brain atrophy.
- The proposed method shows promise for improving the management of hyperacute stroke patients.
- Further prospective studies are planned to validate the clinical impact on treatment decisions.
